Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Tuscaloosa Research & Education Advancement Corporation
With
HYPOTHESES Primary Hypothesis: Compared to placebo treatment, nepicastat-treated OIF/OEF veterans with PTSD will have significantly reduced PTSD hyperarousal symptoms as defined by the Clinician Administered PTSD Scale \[CAPS\], subscale D (CAPS-D). Secondary Hypotheses: Compared to placebo, nepicastat-treated OIF/OEF veterans with PTSD will have: * Significantly reduced PTSD symptoms (total CAPS) * Significantly reduced PTSD reexperiencing symptoms (CAPS-B) * Significantly reduced PTSD avoidance symptoms (CAPS-C)
Age
19–any
Sex
ALL
Healthy volunteers
Accepted